Adlai Nortye Ltd.
NASDAQ:ANL · NASDAQ Global Market
-$0.11 today
Vol 0.04M · Avg 0.35M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
426.9%
avg 29.5%
ROIC
-197.7%
avg -235.2%
ROA
-103.2%
avg -103.1%
Analysis
ROE is currently the strongest return metric at 426.9% versus its period average of 29.5%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Zhiyong Yu | Vice President of Operations | — | — | — | — | — |
Xiaofeng Ye | Chief Financial Officer | — | — | 47 | $31.00 | <0.01% |
Ngai Chiu Tse | President & Head of Research & Development | — | — | 58 | $50,000.00 | 0.09% |
Nanhai He | Head of Discovery | — | — | — | — | — |
Donghui Yang | Chairman of the Greater China Region | — | — | — | $0.00 | <0.01% |
Yang Lu | Co- Founder, Chief Executive Officer & Chairman | — | — | 47 | $0.00 | <0.01% |
Chen Yang | Head of HR & Administration & Government Affairs | — | — | — | $0.00 | <0.01% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
1
$131.80
Net Sentiment
$131.80
Net selling
Most Active
LU YANG
1 transactions
Analysis
Insiders reported 0 buys worth $0.00 and 1 sells worth $131.80 over the last 12 months. That adds up to net selling of $131.80. LU YANG was the most active insider with 1 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | N/A3 analysts |
| Net Income | N/A | N/A | N/A | N/A3 analysts |
| EBIT | N/A | N/A | N/A | N/A3 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Peer companies in the same sector
Tharimmune, Inc.
THAR
$139.94M
Apollomics, Inc.
APLM
$18.54M
BioLineRx Ltd.
BLRX
$13.62M
Lipocine Inc.
LPCN
$13.46M
Adaptimmune Therapeutics plc
ADAP
$12.53M
OSR Holdings, Inc.
OSRH
$9.27M
SeaStar Medical Holding Corporation
ICU
$8.84M
Ainos, Inc.
AIMD
$8.83M
GeoVax Labs, Inc.
GOVX
$1.14M
Aditxt, Inc.
ADTX
$425.00
Who manages ANL?
Adlai Nortye Ltd. (ANL) lists 7 active executives. The top listed executive is Zhiyong Yu, Vice President of Operations.
Are ANL insiders buying or selling?
Recent insider activity shows net buying of $9.95M.
Explore More
Continue the stock analysis
Jump to another research area for this company.